GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Research

Photo for HIP ATTACK

HIP ATTACK

Official Title

HIP fracture Accelerated surgical Treatment And Care track (HIP ATTACK) Trial

Status

Ongoing

Overview

To determine the effect of accelerated medical clearance and accelerated surgery compared to standard care on the 30-day risk of a major perioperative complication (i.e., a composite of mortality, nonfatal myocardial infarction, nonfatal pulmonary embolism, nonfatal pneumonia, nonfatal sepsis, nonfatal stroke, and nonfatal life-threatening and major bleeding).

Study Design

Randomized, multicentre, parallel group design, controlled trial (RCT)

Primary Endpoint

Primary outcome measure: Composite of mortality, nonfatal myocardial infarction, nonfatal pulmonary embolism, nonfatal pneumonia, nonfatal sepsis, nonfatal stroke, and nonfatal life-threatening and major bleeding.

Number of Patients

1200

Number of Sites

15

Number of Countries

10

Study Period

2014–2017

Principal Investigator

P.J. Devereaux, Mohit Bhandari

Program Manager

Shirley Pettit

Research Coordinator

Valerie Dunlop